Amarillo uses last of monoclonal antibody supply

After treating over 5,000 patients at the Amarillo Regional Infusion Center as of Saturday (Jan. 8), the City of Amarillo Public Health Department (APHD) has given all doses of the COVID-19 monoclonal antibodies allocated to date. APHD is awaiting additional shipments of monoclonal antibody, which are anticipated to arrive next week.

Treatments at the clinic will resume pending the next shipment of the COVID-19 monoclonal antibodies from the Texas Department of State Health Services. Once this shipment is received, the clinic will operate as it has since Sept 22. 

“As we expected, Amarillo has used its current supply of the COVID-19 monoclonal antibodies,” said Amarillo Public Health Director Casie Stoughton. “We have an extremely efficient model for rapidly delivering the monoclonal antibodies, and we want to treat as many people as we can as quickly as we can. The fact we were able to provide the COVID-19 monoclonal antibodies so quickly to so many is a good thing. We don’t want the monoclonal antibodies in our refrigerators. We want the monoclonal antibodies to help patients quickly.”

The Amarillo Regional Infusion Center is located at 808 S. Johnson. Staff will continue to receive referrals and screen patients for eligibility in anticipation of the next shipment of monoclonal antibodies. Patients will be called and scheduled for appointment upon receipt of the medication.

Please stay tuned for information on arriving shipments of medication.

Post a Comment

Previous Post Next Post